BioPharmSignal logoBioPharmSignal

Biotech News

Veradigm to Participate in Two Upcoming Investor Conferences

Veradigm (MDRX)VeradigmCompany update

CHICAGO --(BUSINESS WIRE)--Aug. 17, 2026-- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September.

Related news

MDRXVeradigm2026-05-26 12:01 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-02-10 21:01 EST

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

View all latest news

Veradigm

Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.

Recent company news

MDRXVeradigm2026-08-17 12:01 EST

Veradigm to Participate in Two Upcoming Investor Conferences

MDRXVeradigm2026-05-26 20:10 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-05-26 12:01 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-05-06 20:01 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-05-06 12:01 EST

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

Stock data

Close
4.99 USD
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States